Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 5809

Original article / research
Year : 2017 | Month : April | Volume : 11 | Issue : 4 | Page : EC35 - EC38

Expression of Alpha - Methylacyl - Coenzyme A Racemase (AMACR) in Colorectal Neoplasia

Nidhi Shukla, Amit Kumar Adhya, Jaysree Rath

1. Postgraduate Student, Department of Pathology, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India. 2. Associate Professor, Department of Pathology, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India. 3. Professor, Department of Pathology, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India.

Correspondence Address :
Dr. Amit Kumar Adhya,
Associate Professor, Department of Pathology, Kalinga Institute of Medical Sciences,
KIIT, Bhubaneswar-751024, Odisha, India.
E-mail: amitadhya2003@yahoo.com

Abstract

Introduction: Red meat and dairy products have been implicated in colonic cancers. They are rich in branched chain fatty acids which require an enzyme Alpha-Methylacyl-Coenzyme A Racemase (AMACR) for their oxidation. Increased expression of AMACR in colorectal premalignant lesions and carcinomas suggests its possible role in carcinogenesis.

Aim: To study the expression of AMACR in colorectal neoplasia and its correlation with the histological grade, stage and nodal status of colorectal malignancy.

Materials and Methods: All cases of colorectal neoplasms were included in the study. AMACR expression was studied in 56 cases which included 44 cases of adenocarcinoma and 12 cases of adenoma and a normal colonic mucosal tissue was used as a control. A tissue microarray was prepared by manual method. AMACR expression was studied by Immunohistochemistry (IHC) and it was correlated with the grade, stage and nodal status of the cancer. Chi-square test was used for analysis or results. The p-value of <0.05 was considered significant.

Results:Out of 12 cases of adenoma 25% (3/12) were negative; 50% (6/12) showed poor expression, 25% (3/12) had moderate expression and none showed strong expression. Nearly, 34.1% (15/44) case of carcinoma were negative; 45.45% (20/44) had poor; 13.63% (6/44) had moderate and 6.81% (3/44) had a strong expression. Normal colonic tissue showed no expression. There was no significant difference of AMACR expression between adenoma and carcinoma cases. AMACR expression was found to be increased in low grade carcinomas (G1 and G2). G1 showed AMACR positivity in 62% cases and G2 showed 71.4% positivity. No association was found between AMACR expression and different American Joint Committee on Cancer (AJCC) stages and nodal status of CRC.

Conclusion: Increased expression of AMACR in adenomas and carcinomas as compared to non-neoplastic epithelium of colon implies that, it plays a role in colorectal neoplasia. Decreased expression of AMACR in high grade carcinomas suggests its role in differentiation of the tumour.

Keywords

Adenomas, Colorectal cancer, Tissue microarray

How to cite this article :

Nidhi Shukla, Amit Kumar Adhya, Jaysree Rath. EXPRESSION OF ALPHA - METHYLACYL - COENZYME A RACEMASE (AMACR) IN COLORECTAL NEOPLASIA. Journal of Clinical and Diagnostic Research [serial online] 2017 April [cited: 2017 May 29 ]; 11:EC35-EC38. Available from
http://jcdr.net/back_issues.asp?issn=0973-709x&year=2017&month=April&volume=11&issue=4&page=EC35-EC38&id=9727

DOI and Others

DOI: 10.7860/JCDR/2017/25303.9727


Date of Submission: Nov 09, 2016
Date of Peer Review: Dec 19, 2016
Date of Acceptance: Feb 09, 2017
Date of Publishing: Apr 01, 2017


Financial OR OTHER COMPETING INTERESTS: None.

JCDR is now Monthly and more widely Indexed .
  • PubMed Central® (PMC)New
  • Academic Search Complete Database
  • Chemical Abstracts Service
  • Directory of Open Access Journals (DOAJ)
  • EBSCOhostNew
  • Embase & EMbiology
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Open J-Gate
  • Popline (reproductive health literature)
  • SCOPUS
  • www.omnimedicalsearch.com